C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/82 (2006.01) A61K 31/428 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2362705
This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2- yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent.
La présente invention concerne, de manière générale, un composé N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2-yl] urée, des compositions pharmaceutiques renfermant ce composé, ainsi que des méthodes d'utilisation dudit composé dans le traitement des inflammations et comme agent de radiosensibilisation anticancereux.
Duncia John J. V.
Gardner Daniel S. IV
Santella Joseph B. III
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Dupont Pharmaceuticals Company
LandOfFree
N-adamant-1-yl-n'-¬4-chlorobenzothiazol-2-yl| urea useful in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-adamant-1-yl-n'-¬4-chlorobenzothiazol-2-yl| urea useful in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-adamant-1-yl-n'-¬4-chlorobenzothiazol-2-yl| urea useful in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1481260